#044: Shared Decision Making (SDM) for Treatment Success in MS. Interview with Prof. Christoph Heesen

#044: Shared Decision Making (SDM) for Treatment Success in MS. Interview with Prof. Christoph Heesen

Prof. C. Heesen explains what it needs to have shared decision making in MS and where there are the pros and cons, options and limitations.

You can find the transcript of the interview on my blog to read it: https://ms-perspektive.com/044-shared-decision-making

Today's interview is about the topic of shared decision making in the treatment of MS. What requirements must be met to enable shared decision making? How intensively is it already being practiced? What are the advantages and disadvantages of patients deciding together with their neurologist how their personal MS should be treated? I talk about this with Prof. Christoph Heesen, who is passionate about this topic and has already developed a number of information services for the German-speaking patient community to enable patients to make informed decisions.

Introduction – Who is Prof. Dr. Christoph Heesen?

Prof. Christoph Heesen is a Senior physician, Head of the MS-Center and Neurologist at the Medical Center Hamburg-Eppendorf (UKE), Hamburg in Germany. He was already couple of times my guest for the German MS-Perspektive podcast. We talked about stem cell therapy and for whom this treatment is a good option. Another interview concentrated on German patient information tools, established by his team that help to provide patients with information around treatment choices. The platforms include statements from patients that are positive, neutral and negative on certain options to make it balanced.

How and where can interested people find more information on shared decision making in MS or even more generic in medical treatment?

Prof. Christoph Heesen: We have the International Society of Shared Decision-Making. She has a website and a conference every two years, I think. The next will be in Switzerland, if I'm informed right. In terms of disease specific, it depends a lot from of course, a given country and the language. To be honest, I'm not aware that on international grounds, there's really a shared decision making portal for MS patients, who is really working with this concept.

Of course, we have more or less advanced websites, for example, from the UK MS Society, which in general, a lot has this attitude that patients need to make their choices and how to inform patients about that. But with this very shared decision making, a focused approach, this is, it's not really very prevalent. It's maybe sold in a different way and I think the overall attitude in MS centers in larger, at least Western world MS centers is in this direction, but it's not shouted out in this way. So I must confess I'm not really able to provide this. As an international crowd in Germany, we have a couple of tools which you can use. We put most of them of ours in the back, but I'm sorry most of them are…

Nele Handwerker: German only. Yes, but I think it's also worth checking the European MS Society and the International MS Society. At least they try to take their part on patient education and that is, as we defined, of course, one basis for shared decision making. Fantastic. Christoph, thanks a lot. It was a pleasure to talk in English to you, next time in Germany again, I guess. And I hope you out there have now a better understanding and know what is possible, but where also, let's say, yeah, the advantages, the disadvantages, and maybe what's possible, what's not possible. And yeah, thanks a lot. Bye-bye.

---

See you soon and try to make the best out of your life,
Nele

For more information and positive thoughts, subscribe to my newsletter for free.

Click here for an overview of all podcast episodes published so far.

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(192)

#190: Living with multiple sclerosis. Gabriela's story and the "(un)seen faces of MS" Art Project

#190: Living with multiple sclerosis. Gabriela's story and the "(un)seen faces of MS" Art Project

https://ms-perspektive.de/en/190-unseen-faces-of-ms/Living with multiple sclerosis often means experiencing symptoms that others cannot see. Austrian artist Gabriela Romagna shares her journey to an M...

4 Marras 32min

#189: New imaging in MS: understanding progression and finding better treatments | ECTRIMS 2026

#189: New imaging in MS: understanding progression and finding better treatments | ECTRIMS 2026

How could new imaging in MS help us understand progression and develop better treatments? In this episode, I explore key insights from Daniel Reich's MSToronto2026 lecture and related research. Learn ...

28 Loka 15min

#188: Jan Van Amstel on EMSP's Four-Year Presidency and the Future of MS Advocacy in Europe

#188: Jan Van Amstel on EMSP's Four-Year Presidency and the Future of MS Advocacy in Europe

"Get rid of MS as soon as possible and make ourselves superfluous." — Jan van Amstel What can a stronger European voice achieve for people living with MS? In episode #188, EMSP President Jan van Amste...

21 Loka 31min

#187: Aging in multiple sclerosis: relapses, progression and treatment choices with Dr. Yi Chao Foong

#187: Aging in multiple sclerosis: relapses, progression and treatment choices with Dr. Yi Chao Foong

Aging in multiple sclerosis brings new questions about relapses, gradual progression and treatment choices. In episode 187, Dr. Yi Chao Foong, an MS neurologist and researcher in Tasmania, explains wh...

14 Loka 29min

#186: Protecting nerve cells in multiple sclerosis: A new path toward neuroprotection with Prof. Manuel Friese

#186: Protecting nerve cells in multiple sclerosis: A new path toward neuroprotection with Prof. Manuel Friese

Why can multiple sclerosis progress even when relapses are well controlled? In episode 186, I speak with Prof. Manuel Friese about the next challenge in MS research: protecting nerve cells from damage...

7 Loka 43min

#185: Living with MS in Mexico – who gets diagnosed, who gets treated, and who gets left behind?

#185: Living with MS in Mexico – who gets diagnosed, who gets treated, and who gets left behind?

An MS diagnosis can depend on where you live, whether you can reach a neurologist and how quickly you can get an MRI. In this episode, Nele speaks with neurologist and neuroimmunologist Dr. Enrique Go...

30 Syys 36min

#184: MS treatment across the disease course – treat early, think long-term, don't give up too soon with Prof. Klaus Schmierer

#184: MS treatment across the disease course – treat early, think long-term, don't give up too soon with Prof. Klaus Schmierer

Read the full blog post and interview here: https://ms-perspektive.de/en/184-klaus-schmierer/ How early should MS treatment start, how strongly should we treat, and is there ever a point when it becom...

23 Syys 41min

#183: Silent progression in MS. Can we really detect it early?

#183: Silent progression in MS. Can we really detect it early?

Can we detect gradual MS progression before it becomes obvious? In this episode, I look at what current research can — and cannot — tell us about subtle worsening without an obvious relapse. The key d...

16 Syys 34min

Suosittua kategoriassa Koulutus

rss-murhan-anatomia
aamukahvilla
psykopodiaa-podcast
rss-hereilla
voi-hyvin-meditaatiot-2
rss-suomen-aa-podcast
rss-arkea-ja-aurinkoa-podcast-espanjasta
adhd-podi
aloita-meditaatio
kesken
rss-liian-kuuma-peruna
rss-monarch-talk-with-alexandra-alexis
ihminen-tavattavissa-tommy-hellsten-instituutti
rss-luonnollinen-synnytys-podcast
rahapuhetta
rss-vapaudu-voimaasi
rss-xamk-podcast
rss-taysi-voima
rss-koira-haudattuna
psykologia